Skip to main content
Caplight Logo









BioFlyte

BioFlyte

Private
Albuquerque, New MexicoFrontier & Industrial Techhttps://www.bioflyte.com/

Last Round

Series B

Aug 10, 2023

Total Funding Raised

$12.75M

Company Overview

BioFlyte is a biodefense company that develops and commercializes fieldable aerosol mass spectrometers and biothreat surveillance solutions to protect critical infrastructure from biological and chemical threats.

Sector

Frontier & Industrial Tech

Verticals

Defense Tech, Environmental Monitoring, Sensors, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales, Government Contracts, Services & Consulting

AI Layer

Application

Keywords

biodefenseairborne pathogen sensorbiosecurity monitoringaerosol samplingmass spectrometrythreat detectioncritical infrastructure securityreal-time monitoringdefense techbio-surveillancepathogen detectionSBIRdual-use technology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

BioFlyte Comparables

Compare BioFlyte with similar companies based on industry and business-model similarity.

BioFlyte comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Zeteo Tech
83%
Chemring Group PLC
75%
Shanghai Lasensor Photoelectronic Technology Co., Ltd.
74%

BioFlyte Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BAug 10, 2023
Series AApr 19, 2022
SeedJun 9, 2020

Key People

Founding team and executive leadership

Todd Sickles

President And CEO

Executive Team

BioFlyte Investors

Notable investors and investment history

BioFlyte investors
InvestorRounds
Scout VenturesSeries B
New Mexico Vintage FundSeries B
Cottonwood Technology FundSeries B, Series A
Anzu PartnersSeries A, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 23, 2025

    Partnered with Los Alamos National Laboratory for biothreat detection modeling.

  • Feb 5, 2025

    US Air Force to trial dynamic threat monitoring technology.

BioFlyte Filings

Explore SEC and related filing metadata, where available.

BioFlyte filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about BioFlyte's valuation, stock price, and market status.

Is BioFlyte a public or private company?

BioFlyte is a private company.

What is the current stock price of BioFlyte?

BioFlyte is a private company with no public stock price. No recent secondary market data is available.

How much is BioFlyte worth (valuation)?

Valuation information for BioFlyte is not publicly available.

Can I buy BioFlyte stock?

BioFlyte shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was BioFlyte's last funding round?

BioFlyte's most recent funding round was Series B on August 10, 2023.

Who are the main investors in BioFlyte?

Key investors in BioFlyte include Scout Ventures, Cottonwood Technology Fund, Anzu Partners.

Will BioFlyte IPO soon?

No public IPO plans have been announced for BioFlyte.

How can I track BioFlyte secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor BioFlyte's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersAlbuquerque, New Mexico
Employee Range6
Year Founded2020
Last FundingAug 10, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?